COVID-19, virus identified. COVID-19, virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age >18 years Positive polymerase chain reaction (PCR) test for COVID-19 Primary clinical symptoms Hospitalized and moderate patients Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm
Exclusion criteria
Exclusion criteria: Underlying diseases, including renal failure (serum creatinine >2), myocarditis and arrhythmia, anemia (hemoglobin<4-8), lower respiratory tract infection, and asthma Patients requiring intubation or frequent use of respiratory drugs Severe and critical patients History of allergy to studied drug Pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Viral load. Timepoint: Before intervention and 7 days after the start of the intervention. Method of measurement: Polymerase chain reaction (PCR) test.;Body temperature. Timepoint: Before intervention and daily during the study. Method of measurement: Thermometer.;Oxygen saturation. Timepoint: Before intervention and daily during the study. Method of measurement: Pulse oximeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: Time period from admission to discharge. Method of measurement: Patient's file.;C-reactive protein. Timepoint: Before intervention and 7 days after the start of the intervention. Method of measurement: C-RP kit.;Incidence of serious adverse events. Timepoint: Before intervention and daily during the study. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Bandare-abbas University of Medical Sciences